奥利普拉兹对尿道愈合的影响:一项实验性研究
概括
奥尔蒂普拉兹 (OPZ) 在大鼠模型中没有显示尿道愈合的益处. 尿道内OPZ甚至使未受伤的尿道中的纤维化和炎症恶化,表明潜在的危害.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿道狭窄和纤维化是重大的临床挑战.
- 奥尔蒂普拉兹 (OPZ) 正因其潜在的抗纤维和治疗性质而受到研究.
研究的目的:
- 在大鼠模型中评估口服和尿道内奥尔蒂普拉兹 (OPZ) 在促进尿道损伤后愈合和减少纤维化的疗效.
- 评估OPZ在受伤和未受伤尿道中的安全性.
主要方法:
- 通过使用儿科泌尿器瘤,建立了小鼠尿道损伤模型.
- 鼠被随机分为五组:假,尿道损伤 (UI),UI与口服OPZ (UI+oOPZ),UI与尿道内OPZ (UI+iOPZ) 和假与尿道内OPZ (sham+iOPZ).
- 在治疗14天后进行了组织病理学和免疫组织化学分析 (TGF-β1,VEGFR2).
主要成果:
- 在受伤群体中,奥尔蒂普拉斯 (OPZ) 没有对尿道愈合或纤维化产生有益影响.
- 与假装组相比,在没有损伤的情况下 (假+iOPZ) 进行尿道内OPZ的使用导致炎症和海绵纤维化显著增加.
- 在假冒+iOPZ组中观察到VEGFR2和TGF-β1的高得分,这表明存在有害影响.
结论:
- 根据这些发现,Oltipraz (OPZ) 不推用于治疗尿道损伤.
- 输尿管内给予OPZ可能会产生有害影响,即使没有伤害.
- 需要进一步的研究来探索尿道损伤的替代治疗策略.
相关概念视频
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
15
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
15
01:26Peptic Ulcer Disease IV: Management
113
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
113
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
462
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
462
01:25Urinary Tract Infection II: Pathophysiology
20
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
20
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
507
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
507
01:25Urinary Tract Calculi VI: Surgical Management
11
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
11